Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2014

Sep 17, 2014

34519_dirs_2014-09-17_04136b1f-205c-4d42-8c50-1b296404ed43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2014-09-16

Reporting Person: Wainman Paul R (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-09-16 Common Stock, par value $0.10 per share P 225.0000 $4.5000 Acquired 1425.0000 Direct